Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential

Margaillan, Guillaume; Rouleau, Michele; Klein, Kathrin; Fallon, John K.; Caron, Patrick; Villeneuve, Lyne; Smith, Philip C.; Zanger, Ulrich M.; Guillemette, Chantal

dc.contributor.author	Klein, Kathrin
dc.contributor.author	Zanger, Ulrich M.
dc.date.accessioned	2016-01-26T16:17:04Z
dc.date.available	2016-01-26T16:17:04Z
dc.date.issued	2015
dc.identifier.issn	0090-9556
dc.identifier.uri	http://hdl.handle.net/10900/67967
dc.language.iso	en	de_DE
dc.publisher	Amer Soc Pharmacology Experimental Therapeutics	de_DE
dc.relation.uri	http://dx.doi.org/10.1124/dmd.115.065391
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential	de_DE
dc.type	Article	de_DE
utue.quellen.id	20151209042647_00858
utue.publikation.seiten	1331-1335	de_DE
utue.personen.roh	Margaillan, Guillaume
utue.personen.roh	Rouleau, Michele
utue.personen.roh	Klein, Kathrin
utue.personen.roh	Fallon, John K.
utue.personen.roh	Caron, Patrick
utue.personen.roh	Villeneuve, Lyne
utue.personen.roh	Smith, Philip C.
utue.personen.roh	Zanger, Ulrich M.
utue.personen.roh	Guillemette, Chantal
dcterms.isPartOf.ZS-Issue	9	de_DE
dcterms.isPartOf.ZS-Volume	43	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)